Výsledky vyhledávání - "Cranston, RD"

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons

Autor: Rotger, M, Glass, Tr, Junier, T, Lundgren, J, Neaton, Jd, Poloni, Es, van 't Wout AB, Lubomirov, R, Colombo, S, Martinez, R, Rauch, A, Günthard, Hf, Neuhaus, J, Wentworth, D, van Manen, D, Gras, La, Schuitemaker, H, Albini, L, Torti, C, Jacobson, Lp, Li, X, Kingsley, La, Carli, F, Guaraldi, G, Ford, Es, Sereti, I, Hadigan, C, Martinez, E, Arnedo, M, Egaña-Gorroño, L, Gatell, Jm, Law, M, Bendall, C, Petoumenos, K, Rockstroh, J, Wasmuth, Jc, Kabamba, K, Delforge, M, De Wit, S, Berger, F, Mauss, S, de Paz Sierra, M, Losso, M, Belloso, Wh, Leyes, M, Campins, A, Mondi, A, De Luca, A, Bernardino, I, Barriuso-Iglesias, M, Torrecilla-Rodriguez, A, Gonzalez-Garcia, J, Arribas, Jr, Fanti, I, Gel, S, Puig, J, Negredo, E, Gutierrez, M, Domingo, P, Fischer, J, Fätkenheuer, G, Alonso-Villaverde, C, Macken, A, Woo, J, Mcginty, T, Mallon, P, Mangili, A, Skinner, S, Wanke, Ca, Reiss, P, Weber, R, Bucher, Hc, Fellay, J, Telenti, A, Tarr, Pe, Vullo, V, Magnificent, Consortium, Insight, Swiss HIV Cohort Study, Mastroianni, C

Publikováno v: Clinical Infectious Diseases, vol. 57, no. 1, pp. 112-121
Clinical Infectious Diseases, 57(1), 112-121. Oxford University Press
CLINICAL INFECTIOUS DISEASES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Clinical Infectious Diseases
Clinical infectious diseases, 57(1), 112-121. Oxford University Press
Rotger, M.; Glass, T. R.; Junier, T.; Lundgren, J.; Neaton, J. D.; Poloni, E. S.; van 't Wout, A. B.; Lubomirov, R.; Colombo, S.; Martinez, R.; Rauch, Andri; Gunthard, H. F.; Neuhaus, J.; Wentworth, D.; van Manen, D.; Gras, L. A.; Schuitemaker, H.; Albini, L.; Torti, C.; Jacobson, L. P.; ... (2013). Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons. Clinical infectious diseases, 57(1), pp. 112-121. Oxford University Press 10.1093/cid/cit196
Clinical Infectious Diseases, Vol. 57, No 1 (2013) pp. 112-121
Clinical Infectious Diseases, 57(1), 112-21. Oxford University Press

BACKGROUND: Persons infected with human immunodeficiency virus (HIV) have increased rates of coronary artery disease (CAD). The relative contribution of genetic background, HIV-related factors, antiretroviral medications, and traditional risk factors

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::519fd64fa964ede5ec9a489454dd566b
https://serval.unil.ch/resource/serval:BIB_FF946CC0ABE7.P001/REF.pdf

Zobrazit plný text záznamu

Akademický článek

Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.

Autor: Bernal S; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Department of Infectious Diseases and Immunity, School of Medicine, University of Vic-Central University of Catalonia, Vic, Spain., Puertas MC; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Morón-López S; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Cranston RD; Department of Infectious Diseases, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain., Urrea V; IrsiCaixa AIDS Research Institute, Badalona, Spain., Dalmau J; IrsiCaixa AIDS Research Institute, Badalona, Spain., Salgado M; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.; Germans Trias i Pujol Research Institute, Badalona, Spain., Gálvez C; IrsiCaixa AIDS Research Institute, Badalona, Spain., Erkizia I; IrsiCaixa AIDS Research Institute, Badalona, Spain., McGowan I; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Scherrer D; Abivax, Paris, France., Revollo B; Fundació Lluita contra les Infeccions, Badalona, Spain.; Department of Infectious Diseases, University Hospital Germans Trias i Pujol, Badalona, Spain., Sirera G; Fundació Lluita contra les Infeccions, Badalona, Spain.; Department of Infectious Diseases, University Hospital Germans Trias i Pujol, Badalona, Spain., Santos JR; Fundació Lluita contra les Infeccions, Badalona, Spain.; Department of Infectious Diseases, University Hospital Germans Trias i Pujol, Badalona, Spain., Clotet B; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Department of Infectious Diseases and Immunity, School of Medicine, University of Vic-Central University of Catalonia, Vic, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.; Fundació Lluita contra les Infeccions, Badalona, Spain.; Department of Infectious Diseases, University Hospital Germans Trias i Pujol, Badalona, Spain., Paredes R; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Department of Infectious Diseases and Immunity, School of Medicine, University of Vic-Central University of Catalonia, Vic, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.; Fundació Lluita contra les Infeccions, Badalona, Spain.; Department of Infectious Diseases, University Hospital Germans Trias i Pujol, Badalona, Spain., Martinez-Picado J; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Department of Infectious Diseases and Immunity, School of Medicine, University of Vic-Central University of Catalonia, Vic, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.; Germans Trias i Pujol Research Institute, Badalona, Spain.; Catalan Institution for Research and Advanced Studies, Barcelona, Spain.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2023 Nov 02; Vol. 228 (9), pp. 1280-1291.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání